Gene · 80331
NIH grants1,608
NIH grants whose papers are about the gene, through NIH's grant-paper links.
661 to 680 of 1,608
Download this page as JSON| Grant | Title | DNAJC5 papers | Newest fiscal year |
|---|---|---|---|
| R01GM123055 | Structural Modeling of Multifarious Protein Complexes | 1 | 2020 |
| R01GM123455 | Toolkit for High-Resolution Structure and Dynamics of Functional Lipids | 1 | 2020 |
| R01MH109706 | Linking Ciliary Biology to the Functional Annotation of Psychiatric Distorders | 1 | 2020 |
| R01NS098516 | Mechanisms of HIPK2 in neurodegeneration | 1 | 2020 |
| R03AI144143 | A Pilot Study to Evaluate Plasmodium falciparum Liver-Stage Challenge in Prime-and-Trap Vaccinated Rhesus Monkeys | 1 | 2020 |
| R13NS040925 | Neurobiology of Disease in Children Conferences | 1 | 2020 |
| R21AI141367 | Plasmodium phospholipase A2s as potential novel drug targets | 1 | 2020 |
| R21AI143932 | Are all sporozoites equal? Analyses of transcriptomes from individual Plasmodium sporozoites using single cell RNA-seq | 1 | 2020 |
| R21AI144705 | Eicosanoid regulation of mosquito innate immunity | 1 | 2020 |
| R21GM132705 | MIRROR: A Chip-Scale Mid-IR Ring Resonance System for On-the-fly Reporting of Analytes | 1 | 2020 |
| R21NS117855 | Cysteine-string Protein and Neurodegeneration | 1 | 2020 |
| R37GM065204 | Functions of thioredoxin reductases and their targets | 1 | 2020 |
| R44AI079898 | Development of a Yellow Fever Vaccine for a Vulnerable Population | 1 | 2020 |
| R56AI148426 | A Nanoparticle-Based Multivalent Rotavirus Vaccine | 1 | 2020 |
| R61DA047023 | POLYCOMB REPRESSIVE COMLEXE AS KEY REGULATORS OF HIV LATENCY AND TARGETS FOR LATENCY REVERSAL | 1 | 2020 |
| RF1AG062479 | The complex interaction between Alzheimer drivers and aging | 1 | 2020 |
| RF1AG069334 | Connecting nuclear functions of Tau with pathology in Alzheimer's disease and other Tauopathies | 1 | 2020 |
| T32CA108459 | Training Program in Oncogenic Signals and Chromosome Biology | 1 | 2020 |
| T32GM007337 | Medical Scientist Training Program | 1 | 2020 |
| T32GM008515 | Chemistry Biology Interface Predoctoral Training Grant | 1 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80331/grants?page=34